LY-320135

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLY-320135
Drug Alias NameLY-320135
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor antagonists
TargetsCannabinoid receptor
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A